SEC Comment Letter 0000000000-24-006439 to Zivo Bioscience, Inc. (ZIVO, ZIVOW) (CIK 0001101026) (ZIVO)
Zivo Bioscience, Inc. (ZIVO, ZIVOW) (CIK 0001101026)
Date: June 5, 2024 · CIK: 0001101026 · Accession: 0000000000-24-006439
AI Filing Summary & Sentiment
File numbers found in text: 001-40449
Letter
United States securities and exchange commission logo June 5, 2024 Keith Marchiando Chief Financial Officer Zivo Bioscience, Inc. 21 East Long Lake Road , Suite 100 Bloomfield Hills , MI 48304 Re:Zivo Bioscience, Inc. Form 10-K for the Fiscal Year Ended December 31, 2023 Filed March 15, 2024 File No. 001-40449 Dear Keith Marchiando: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
June 5, 2024
Keith Marchiando
Chief Financial Officer
Zivo Bioscience, Inc.
21 East Long Lake Road , Suite 100
Bloomfield Hills , MI 48304
Re:Zivo Bioscience, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2023
Filed March 15, 2024
File No. 001-40449
Dear Keith Marchiando:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences